MS CATCH is a phase II 12-month pragmatic clinical treatment trial enrolling diverse PwMS with mild to moderately severe self-reported mood using simple stepped wedge design (figure 2).
Overview of trial design and outcomes. A 12-month, delayed-start, randomised phase II clinical trial evaluating the efficacy (behaviours, mood) and usability of a closed loop tool for comprehensive real-time depression care in MS. HADS-D, Hospital Anxiety Depression Scale-Depression; MS, multiple sclerosis; MS CATCH, Care technology to Ascertain, Treat and engage the Community to Heal depression in patients with MS.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.